Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder

Journal of Neurochemistry

Volumn 127, Issue 4, 2013, Pages 552-561

  Andreazza, Ana C ^a,b   Wang, Jun Feng ^c   Salmasi, Faraz ^a   Shao, Li ^d   Young, Lionel T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

antioxidant enzymes; bipolar disorder; mitochondrial dysfunction; oxidative stress; synapses

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; 8 ISOPROSTANE; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; MYELIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CARBONYLATION; CELL ISOLATION; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIPID PEROXIDATION; MITOCHONDRION; NITROSATIVE STRESS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTMORTEM CHANGE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SYNAPTOSOME;

ANTIOXIDANT ENZYMES; BIPOLAR DISORDER; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; SYNAPSES;

BIPOLAR DISORDER; CASE-CONTROL STUDIES; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX III; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREFRONTAL CORTEX; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; SYNAPTOSOMES; TYROSINE;

EID: 84887029966     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12316     Document Type: Article

References (70)

1. Adam-Vizi V., and, Starkov A. A., (2010) Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J. Alzheimers Dis. 20 (Suppl 2), S413-S426.
2. Agostinho F. R., Jornada L. K., Schröder N., Roesler R., Dal-Pizzol F., and, Quevedo J., (2007) Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain. Neurochem. Res. 32, 1343-1350.
3. Agostinho F. R., Réus G. Z., Stringari R. B., Ribeiro K. F., Pfaffenseller B., Stertz L., Panizzutti B. S., Kapczinski F., and, Quevedo J., (2011) Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex. Neurosci. Lett. 497, 99-103.
4. Altamura A. C., Serati M., Albano A., Paoli R. A., Glick I. D., and, Dell'Osso B., (2011) An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur. Arch. Psychiatry Clin. Neurosci. 261, 489-508.
5. Andreazza A. C., (2012) Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders. Mol. BioSyst. 8, 2503-2512.
6. Andreazza A. C., Cassini C., Rosa A. R., et al,. (2007) Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 41, 523-529.
7. Andreazza A. C., Kauer-Sant'anna M., Frey B. N., Bond D. J., Kapczinski F., Young L. T., and, Yatham L. N., (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 111, 135-144.
8. Andreazza A. C., Kapczinski F., Kauer-Sant'Anna M., Walz J. C., Bond D. J., Goncalves C. A., Young L. T., and, Yatham L. N., (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34, 263-271.
9. Andreazza A. C., Shao L., Wang J. F., and, Young L. T., (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67, 360-368.
10. Andreazza A. C., and, Young L. T., (2013) The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol. 1, 1-14.
11. Banigan M. G., Kao P. F., Kozubek J. A., et al,. (2013) Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8, e48814.
12. Beal M. F., (2002) Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32, 797-803.
13. Beckman J. S., and, Koppenol W. H., (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437.
14. Berk M., Dodd S., Kauer-Sant'anna M., Malhi G. S., Bourin M., Kapczinski F., and, Norman T., (2007) Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. Suppl. 433, 41-49.
15. Berk M., Kapczinski F., Andreazza A. C., et al,. (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35, 804-817.
16. Bongarzone E. R., Pasquini J. M., and, Soto E. F., (1995) Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J. Neurosci. Res. 41, 213-221.
17. Brenner-Lavie H., Klein E., Zuk R., Gazawi H., Ljubuncic P., and, Ben-Shachar D., (2008) Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia. Biochim. Biophys. Acta 1777, 173-185.
18. Clay H. B., Sillivan S., and, Konradi C., (2010) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29, 311-324.
19. Crecelius A., Götz A., Arzberger T., Fröhlich T., Arnold G. J., Ferrer I., and, Kretzschmar H. A., (2008) Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 8, 1276-1291.
20. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., and, Milzani A., (2003) Protein carbonylation in human diseases. Trends Mol. Med. 9, 169-176.
21. Dietrich-Muszalska A., Malinowska J., Olas B., Głowacki R., Bald E., Wachowicz B., and, Rabe-Jabłońska J., (2012) The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem. Res. 37, 1057-1062.
22. Dunkley P. R., Jarvie P. E., and, Robinson P. J., (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat. Protoc. 3, 1718-1728.
23. Frey B. N., Andreazza A. C., Houenou J., et al,. (2013) Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust. N. Z. J. Psychiatry 47 (4), 321-332.
24. García-Heredia J. M., Díaz-Moreno I., Nieto P. M., Orzáez M., Kocanis S., Teixeira M., Pérez-Payá E., Díaz-Quintana A., and, De la Rosa M. A., (2010) Nitration of tyrosine 74 prevents human cytochrome c to play a key role in apoptosis signaling by blocking caspase-9 activation. Biochim. Biophys. Acta 1797, 981-993.
25. Gigante A. D., Young L. T., Yatham L. N., Andreazza A. C., Nery F. G., Grinberg L. T., Heinsen H., and, Lafer B., (2010) Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14, 1075-1089.
26. Goldstein B. I., Fagiolini A., Houck P., and, Kupfer D. J., (2009) Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord. 11, 657-662.
27. Green D. R., and, Kroemer G., (2004) The pathophysiology of mitochondrial cell death. Science 305, 626-629.
28. Grune T., Reinheckel T., and, Davies K. J., (1996) Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 271, 15504-15509.
29. Grune T., Reinheckel T., and, Davies K. J., (1997) Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534.
30. Halliwell B., (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
31. Halliwell B., (2006) Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 1634-1658.
32. Halliwell B., and, Gutteridge J. M., (1984) Free radicals, lipid peroxidation, and cell damage. Lancet 2, 1095.
33. Halliwell B., and, Gutteridge J. M. C., (2007) Free Radicals in Biology and Medicine. Clarendon Press, Oxford.
34. Irie Y., Saeki M., Kamisaki Y., Martin E., and, Murad F., (2003) Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc. Natl Acad. Sci. USA 100, 5634-5639.
35. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., and, Kato T., (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 9, 406-416.
36. Iwamoto K., Bundo M., and, Kato T., (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14, 241-253.
37. Janssen R. J., Nijtmans L. G., van den Heuvel L. P., and, Smeitink J. A., (2006) Mitochondrial complex I: structure, function and pathology. J. Inherit. Metab. Dis. 29, 499-515.
38. Kato T., (2008) Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? Trends Neurosci. 31, 495-503.
39. Kimura H., Liu S., Yamada S., Uchida K., Matsumoto K., Mukaida M., and, Yoshida, K.-i., (2005) Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endo-toxemia. Free Radic. Res. 39, 845-851.
40. King T. D., and, Jope R. S., (2005) Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress. NeuroReport 16, 597-601.
41. Kirsch M., Lehnig M., Korth H. G., Sustmann R., and, de Groot H., (2001) Inhibition of peroxynitrite-induced nitration of tyrosine by glutathione in the presence of carbon dioxide through both radical repair and peroxynitrate formation. Chemistry 7, 3313-3320.
42. Konradi C., Eaton M., MacDonald M. L., Walsh J., Benes F. M., and, Heckers S., (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61, 300-308.
43. Konradi A. O., Rotar O. P., Korostovtseva L. S., Ivanenko V. V., Solntcev V. N., Anokhin S. B., Bart V. A., and, Shlyakhto E. V., (2011) Prevalence of metabolic syndrome components in a population of bank employees from St. Petersburg, Russia. Metab. Syndr. Relat. Disord. 9, 337-343.
44. Konradi C., Sillivan S. E., and, Clay H. B., (2012) Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol. Dis. 45, 37-47.
45. Lai J. S., Zhao C., Warsh J. J., and, Li P. P., (2006) Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539, 18-26.
46. Lenaz G., (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52, 159-164.
47. Ly H. K., Utesch T., Díaz-Moreno I., García-Heredia J. M., De La Rosa M. A., and, Hildebrandt P., (2012) Perturbation of the redox site structure of cytochrome c variants upon tyrosine nitration. J. Phys. Chem. B. [Epub ahead of print].
48. Mattson M. P., and, Liu D., (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med. 2, 215-231.
49. McCord J. M., and, Fridovich I., (1988) Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5, 363-369.
50. Merikangas K. R., Jin R., He J. P., et al,. (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68, 241-251.
51. Nakagawa H., Komai N., Takusagawa M., Miura Y., Toda T., Miyata N., Ozawa T., and, Ikota N., (2007) Nitration of specific tyrosine residues of cytochrome C is associated with caspase-cascade inactivation. Biol. Pharm. Bull. 30, 15-20.
52. Naoi M., Maruyama W., Shamoto-Nagai M., Yi H., Akao Y., and, Tanaka M., (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol. Neurobiol. 31, 81-93.
53. O'Brien J. S., and, Sampson E. L., (1965) Myelin Membrane: a molecular abnormality. Science 150, 1613-1614.
54. Osoata G. O., Yamamura S., Ito M., Vuppusetty C., Adcock I. M., Barnes P. J., and, Ito K., (2009) Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem. Biophys. Res. Commun. 384, 366-371.
55. Power J. H., and, Blumbergs P. C., (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol. 117, 63-73.
56. Reeve A. K., Krishnan K. J., and, Turnbull D. M., (2008) Age related mitochondrial degenerative disorders in humans. Biotechnol. J. 3, 750-756.
57. Rosenfeld M., Brenner-Lavie H., Ari S. G., Kavushansky A., and, Ben-Shachar D., (2011) Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol. Psychiatry 69, 980-988.
58. Rydén E., Johansson C., Blennow K., and, Landén M., (2009) Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. J. Neural Transm. 116, 1667-1674.
59. Schulze T. G., Akula N., Breuer R., et al,. (2012) Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World J. Biol. Psychiatry [Epub ahead of print].
60. Scola G., Kim H. K., Young L. T, and, Andreazza A. C., (2013) A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol. Psychiatry 73, e4-e5.
61. Sies H., (1991) Oxidative stress: from basic research to clinical application. Am. J. Med. 91, 31S-38S.
62. Sun X., Wang J. F., Tseng M., and, Young L. T., (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J. Psychiatry Neurosci. 31, 189-196.
63. Tan H., and, Wang J. F., (2011) Lithium inhibits amphetamine-induced 4-hydroxynonenal-protein adductions in rat frontal cortex. Biol. Psychiatry 69, 223S-224S.
64. Versace A., Andreazza A. C., Young L. T., et al,. (2013) Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol. Psychiatry [Epub ahead of print].
65. Wang J. F., (2007) Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Can. J. Psychiatry 52, 753-762.
66. Wang J. F., Shao L., Sun X., and, Young L.T., (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 11, 523-529.
67. Williams L., Jacka F., Pasco J., Henry M., Dodd S., Nicholson G., Kotowicz M., and, Berk M., (2010) The prevalence of mood and anxiety disorders in Australian women. Australas. Psychiatry 18, 250-255.
68. Williams H. J., Norton N., Dwyer S., et al,. (2011) Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 16, 429-441.
69. Wong C. M., Marcocci L., Liu L., and, Suzuki Y. J., (2010) Cell signaling by protein carbonylation and decarbonylation. Antioxid. Redox Signal. 12, 393-404.
70. Yatham L. N., Liddle P. F., Lam R. W., Adam M. J., Solomons K., Chinnapalli M., and, Ruth T. J., (2005) A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disord. 7 (Suppl 5), 53-57.